comparemela.com

Latest Breaking News On - Pre license inspection - Page 4 : comparemela.com

Appendix 4C Quarterly Activity Report for Quarter Ended

Mesoblast Reports Operational and Financial Highlights for

Mesoblast Reports Operational and Financial Highlights for Quarter Ended March 31, 2023

26.05.2023 - NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) - Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported operational highlights and financial results for the period ended March .

Mesoblast [ASX:MSB] Trims Losses US$2 7 Million and Shares Rise

Biotech company Mesoblast has released its Q3 financial report, saying that it cut losses after tax to US$18.6 million from US$21.3 million a year ago. Shares rose more than 4% during the group’s quarter improvement.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.